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ABSTRACT - PURPOSE: Our working hypothesis is that single bioactive phytochemicals with antioxidant
properties that are important constituents of Traditional Chinese Medicine (TCM) and their defined mixtures have
potential as chemoprotective agents for chronic conditions characterized by oxidative and nitrosative stress,
including Alzheimer’s. Here we evaluate the ability of baicalein, crocetin, trans-resveratrol or schisanhenol and
two defined mixtures of these TCM phytochemicals to attenuate the toxicity resulting from exposure to cell
permeant t-butyl hydroperoxide (tBPH) in wild-type and bioengineered (to express choline acetyltransferase)
HEK 293 cells. METHODS: Endpoints of tBHP-initiated oxidative and nitrosative stress in both types of HEK
293 cells and its attenuation by TCM constituents and mixtures included cytotoxicity (LDH release); depletion of
intracellular glutathione (GSH); formation of S-glutathionylated proteins; oxidative changes to the disulfide
proteome; and real-time changes in intracellular redox status. RESULTS: At low µM concentrations, each of the
TCM constituents and mixtures effectively attenuated intracellular toxicity due to exposure of HEK 293 cells to
50 or 250 µM tBHP for 30 min to 3 h. Confocal microscopy of HEK 293 cells transfected with mutated green
fluorescent protein (roGFP2) showed effective attenuation of tBHP oxidation by baicalein in real time. Three
redox-regulated proteins prominent in the disulfide proteome of HEK 293 cells were identified by MALDI-TOF
mass spectrometry. CONCLUSIONS: We conclude that single TCM chemicals and their simple mixtures have
potential for use in adjunct chemoprotective therapy. Advantages of mixtures compared to single TCM
constituents include the ability to combine compounds with varying molecular mechanisms of cytoprotection for
enhanced biological activity; and to combine chemicals with complementary pharmacokinetic properties to
increase half-life and prolong activity in vivo.
This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For
Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.
__________________________________________________________________________________________
RNS overwhelm these normal detoxication
pathways and contribute to several chronic diseases,
including AIDS, atherosclerosis, cancer, diabetes,
and neurodegenerative disorders such as
Alzheimer’s and Parkinson’s disease (4-7). Thus,
decreased formation and/or increased detoxication of
ROS and RNS can attenuate the severity of chronic
disease caused or promoted by toxic free radicals.
_________________________________________

INTRODUCTION
Reactive oxygen species (ROS)(1) and reactive
nitrogen species (RNS)(2) are formed as by-products
during normal cellular metabolism. In healthy
mammalian cells, physiological concentrations of
ROS and RNS are detoxified by enzymatic
antioxidants including catalase, enzymes of the
glutathione (GSH) oxidation-reduction cycle [GSH
reductase and GSH peroxidase], the peroxiredoxins
(prxs), and superoxide dismutase (SOD) in addition
to the common non-enzymatic antioxidants GSH,
Vitamins C and E, β-carotene and uric acid (3).
Increased, pathological concentrations of ROS and
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Crocetin (Cro) [(2E,4E,6E,8E,10E,12E,14E)2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14heptaenedioic acid] (Figure 1D) is a carotenoid that
provides the colour to Saffron extracts and is its
major active ingredient (25). The presence of seven
trans-conjugated 1,3-double bonds accounts for its
antioxidant properties (25). Of significance, Cro is a
much more potent intracellular antioxidant than
when tested in cell free systems (26), acting by
reducing superoxide anion radical (O2 •-)
production. In cells, Cro is also able to capture the
sulfite radical anion, SO•3- (26). Repeated
administration of Cro also induces the activity of the
important antioxidant enzymes, GSH S-transferase
and GSH peroxidase (25).
Trans-resveratrol
(Res)
[5-[(E)-2-(4hydroxyphenyl)ethenyl]benzene-1,3-diol] (Figure
1C) a phytoalexin that is more stable than its cisisomer, primarily owes its antioxidant activity to its
three phenolic groups, two ortho hydroxyls in one
benzeneoid ring and one para group in the second
ring (27). Mechanistic studies showed the parahydroxyl group scavenges free radicals more
effectively than its ortho-hydroxyl groups (28). Res
directly scavenges superoxide anion and hydroxyl
radicals (28), and reduces their formation by
inhibiting xanthine oxidase activity (29).
Schisanhenol
(Sal)
[5,6,7,8-tetrahydro2,3,10,11,12-pentamethoxy-6,7-dimethyldibenzo(a,c)cycloocten-1-ol] (Figure 1A) is a
dibenzocyclooctene lignin isolated from Schisandra
rubriflora Rhed, an herb common in TCM
prescriptions (30). Studies with this purified TCM
are uncommon because of its restricted availability.
Sal effectively targets mitochondria due to its
enhanced lipophilicity (5 methoxylated phenolic
groups) compared to compounds with only free
antioxidant polyphenols (30), an important reason
for our interest in this compound. Prior to
cytochrome P-450-dependent O-demethylation, its
antioxidant activity is due to a single phenolic
hydroxyl group. Metabolic O-demethylation
liberates 5 additional antioxidant phenolic hydroxyls
in this molecule. Sal inhibits lipid peroxidation (31),
swelling, and reduction of mitochondrial membrane
fluidity due to ROS-mediated damage (32). Sal is a
strong scavenger of superoxide anion (O2 •-), alkyl
(R•-), alkoxy (RO•-), and carboxy (ROO•-) radicals
(33). Repeated treatment of rats induces antioxidant
superoxide dismutase and catalase activities in liver
cytosol (34). To date, there have been no detailed

Their antioxidant activity is one explanation for the
chemoprotective and neuroprotective effects of
several foods and dietary supplements (8,9), and for
some of the therapeutic effects of plant-based TCM
(10).
The association between the administration of
potent antioxidants and the attenuation of free
radical-induced disease (3,9,10) influenced our
choice of specific TCM constituents for evaluation
both in a recent study of sulfamethoxazole Nhydroxylamine(SMX-NHOH-)
mediated
cytotoxicity in Jurkat E6.1 cells (11) and in the
present study. Here, we evaluated the
chemoprotectant effects of these four major TCM
constituents (baicalein (BE), crocetin (Cro), transresveratrol (Res) and schisanhenol (Sal) and two
defined mixtures against the well characterized, cellpermeant oxidative and nitrosative stressor, tertiarybutyl hydroperoxide (tBHP) (12,13) in wild-type
(WT) transformed human renal epithelial cells (HEK
293) cells and HEK 293 cells bioengineered to
express the cholinergic neuron-specific enzyme
choline acetyltransferase (ChAT, EC 2.3.1.6) (14,15)
(ChAT-HEK 293 cells). Recognizing that TCMs
also have cytoprotective effects due to modulation of
cell signalling pathways (16-19), we sought to
optimize the opportunity for complementary
biological activity in our defined mixtures by
selecting four TCM antioxidants of varying structure
and chemical class (Figure 1) with known and
diverse
mechanisms
of
antioxidant
and
cytoprotective activity.
Baicalein
(BE)
[5,6,7-trihydroxy-2phenylchromen-4-one] (Figure 1B) (16,20-24) is the
flavonoid found at highest concentration in the root
of Scutellaria baicalensis, a common component of
TCM prescriptions. The di-ortho phenolic hydroxyl
group on benzeneoid ring-A of BE is associated with
efficient divalent metal ion chelation and free radical
scavenging properties, accounting for its antioxidant
properties (20,23,24). In addition, repeated treatment
with BE reduces the production of ROS by the
upregulation of peroxiredoxin-6 (prx-6) (24), which
decreases intracellular H2O2 content. BE also inhibits
the production of iNOS after stimulation with LPS,
resulting in the attenuated release of the proinflammatory cytokines IL-1β, IL-6, and TNF-α
(24). BE decreases lipid peroxidation and protects
against DNA damage by forming stable semiquinone
radicals, and blocks mitochondrial depolarization
(24).
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GSSP derivatives, and to protein-protein disulfides
(PSSP) when GSH is depleted, occurs selectively in
response to ROS or the RNS, NO (as NO-GSH).
These changes, including the protein disulfides
formed, are the disulfide proteome (7,35,36).
Consequently,
we
compared
the
Sglutathionylation of intracellular proteins in WTHEK 293 cells and ChAT-HEK 293 cells treated
with tBHP, the latter to determine if ChAT is a redox
regulated protein. This is of importance because
ChAT is a critical enzyme in cholinergic neurons
whose activity decreases early in the development of
Alzheimer’s (14,15). In addition, we analyzed tBHPmediated changes to the disulfide proteome of HEK
293 cells by reductive two-dimensional (R2D) SDSPAGE and the attenuation of these changes by pretreatment with Sal, BE, Cro or Res, (Figure 1) alone
or as two equimolar TCM mixtures. In
supplementary experiments, attenuation of tBHP
initiated cytotoxicity (studied by LDH release) and
GSH depletion were studied with some but not all
TCM treatments. Changes in intracellular redox
potential in HEK 293 cells transfected with mutated
green fluorescence protein (roGFP2) were followed
in real time by confocal microscopy immediately
after exposure to tBHP. The ability of BE, a well
investigated TCM antioxidant, to attenuate these
effects was also evaluated.
Finally, we identified three of the important
redox regulated proteins in the disulfide proteome of
HEK 293 cells by MALDI-TOF MS analysis of ingel tryptic digests of proteins separated by R2D SDS
PAGE.

studies of the effects of Sal on cell signalling
networks.
In a recent study (11), we showed these
individual TCM constituents and two defined
mixtures
effectively
attenuated
the
oxidative/nitrosative stress-mediated cytotoxicity of
sulfamethoxazole N-hydroxylamine (SMX-NHOH),
a toxic reactive metabolite of sulfamethoxazole, in
Jurkat E6.1 cells. More specifically, pre-treatment of
cells with 5 µM MIX or MIX-S for 30 min prior to
incubation with 400 µM SMX-NHOH for 2 h
decreased cytotoxicity by 93.4 ± 0.8% (mean ±
SEM, N = 3) and 93.1±0.4%, respectively. By
comparison, the least effective TCM, 5 µM BE,
inhibited cytotoxicity by 57.5 ±1.91% (P<0.05 vs
MIX (equimolar amounts of BE, Cro, Res, Sal) or
MIX-S (equimolar BE, Cro, Res) and the most
effective, Sal attenuated SMX-NHOH toxicity by
82.4 ±1.3% (P<0.05 vs BE). These data encouraged
us to investigate these TCM mixtures in further
detail.
Low and moderate intracellular oxidative stress
can cause reversible post-translational modification
of proteins, compromising enzyme activity by
altering protein structure and conformation. SGlutathionylated
proteins
(PSSG;
proteinglutathione mixed disulfides) are formed by both
ROS and RNS at reactive (ionized) cysteine thiol
residues upon reaction with GSH. As a cell recovers
from oxidative/nitrosative stress these disulfides are
reduced to GSH and PSH, restoring homeostasis
(7,35,36). The conversion of reactive (increased
electrophilicity) cysteine thiols in proteins to their

Figure 1: Chemical structures of the phytochemicals studied. A, Schisanhenol (Sal); B, Baicalein (BE); C, trans-Resveratrol
(Res); and D, Crocetin (Cro) (From PubChem Public Database, http://pubchem.ncbi.nlm.nih.gov)
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a 96-well culture plate for 24 h before treatment.
Culture media was replaced with phosphate buffered
saline (PBS) before antioxidant treatment (0-100 μM
for 30 min). Cells were then treated for 3 h with 0500 µM tBHP or the detergent 1% Triton X-100
(which released all LDH) for cytotoxicity. After
incubation, cell supernatant (100 μL) was removed
and incubated with LDH Reaction Mixture (100 μL).
Released LDH activity was analyzed by measuring
absorbance at 490 nm (Safire F129013, Tecan,
Austria) and correction for LDH release in solvent
controls.

MATERIALS AND METHODS
Chemicals
1-Chloro-2,4-dinitrobenzene (DNCB), dithiothreitol
(DTT), ethyl glutathione (EtGSH), GSH, GSSG,
GSH S-transferases, iodoacetamide (IACD), tBHP,
Cro, Res and N-methylphenazonium methyl sulfate
(PMS) were purchased from Sigma-Aldrich
(Oakville, ON, Canada). The anti-GSH monoclonal
antibody was obtained from Virogen (Watertown,
MA, USA), the anti-β-actin monoclonal from Sigma,
and the anti-ChAT CTab polyclonal antibody was
prepared by Genemed Synthesis (San Antonio, TX,
USA) (14). All other chemicals were purchased
from BDH (Toronto, ON, Canada), EMD (San
Diego, CA, USA) or Sigma-Aldrich and were the
highest purity commercially available.
Cell Culture and Treatments
Constituents and Mixtures

with

Determination of Intracellular
(GSH) Concentration

Glutathione

Cells were plated at 8x105 cells/well in 6-well plates
and cultured for 24 h. Cells were incubated with
TCM constituents (10-50 μM for 30 min), then
treated with 0-500 μM tBHP for 30 min and
centrifuged for 5 min at 500xg. Cell pellets were
resuspended in 250 μL lysis buffer (10 mM Tris, 130
mM NaCl, 10 mM NaF, 10 mM NaH2PO4, 10 mM
Na4P2O7, 2 mM EDTA) and frozen in liquid
nitrogen. Cell lysates were thawed at room
temperature and aliquots taken for protein analysis
(Bradford Bio-Rad Assay Kit). Remaining lysate
was centrifuged for 2 min at 14,000xg and
supernatant collected for GSH analysis by the GSH
S-transferase enzymatic method (39). Supernatant
(50 μL) and 0.1 M potassium phosphate buffer (140
μL, pH 7.6) were added to a 96-well plate to which
were added 40 mM ethanolic DNCB (5 μl) and GSH
S-transferase (0.2 U). Reaction mixtures were
incubated in the dark at room temperature for 20 min
and the S-2,4-dinitrophenyl GSH formed quantitated
by absorbance at 340 nm (39). To quantify GSSG,
aliquots of the same incubation mixtures used for
GSH analysis were treated with NADPH and GSH
reductase to convert all GSSG to GSH; then Total
GSH content equalled the amount of S-2,4dinitrophenyl GSH present after reduction of GSSG.
Sample GSSG content was calculated as the
difference between Total GSH (GSH + GSSG) and
Sample GSH content.

TCM

WT-HEK 293 (ATCC® CRL-1573™) cells were
obtained from ATCC (Manassas, VA, USA) and
maintained in a humidified atmosphere at 37°C and
5% CO2 in Eagle’s Minimum Essential Medium
(Gibco, Carlsbad, CA) supplemented with 10% fetal
bovine serum (FBS), 26 mM NaHCO3 and 10 µg/mL
gentamycin sulfate. WT- or ChAT-HEK 293 cells
(preparation described in 14) were plated 24 h prior
to treatment and then incubated with various
concentrations (10 - 100 µM) of Sal, BE, Res or Cro
individually, or with a mixture of the four
antioxidants at equimolar concentrations (MIX), or
an equimolar mixture of BE, Res and Cro without Sal
(MIX-S) for 30 min. Following this incubation step,
cells were exposed to either 50 or 250 µM tBHP for
30 min to 3 h. The effects of MIX-S were tested to
determine whether Sal was a significant contributor
to the protective effects of the complete mixture
(MIX). Solutions of antioxidants were freshly
prepared in dimethyl sulfoxide (DMSO), and cells
were treated with TCM in no more than 0.2%
DMSO. Protein concentrations were determined
using the Lowry procedure (37).

Intracellular Redox Status Determined with
Transiently Transfected roGFP2

Lactate Dehydrogenase (LDH) Activity
Cytotoxicity was examined by measuring release of
intracellular LDH activity with a colorimetric assay
described in detail elsewhere (11,38). Briefly, WTor ChAT-HEK 293 cells were plated at 8x104 cells in

Intracellular redox status of HEK 293 cells was
measured in real time by confocal laser scanning
microscopy (LSM 510 META, Carl Zeiss Advanced
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mouse or anti-rabbit secondary antibody (1:10,000
dilution)
(Amersham
Biosciences,
Buckinghamshire, England). Detection was
performed using ECL PlusTM Western blotting
reagents (Amersham Biosciences).

Imaging Microscopy, Germany) using a novel
redox-sensitive mutated green fluorescent protein
(roGFP2) (40,41) in which two cysteine residues
were introduced near the chromophore site (S147C
and Q204C). Under oxidizing conditions, a
reversible intramolecular disulfide bond is formed
between these two cysteine thiols resulting in
increased fluorescence excitability at 405 nm and
decreased excitability at 488 nm (emission 530 nm)
so that oxidized and reduced forms of the transfected
roGFP can be quantified. For these experiments,
either WT- or ChAT-HEK 293 cells were plated at a
density of 1x106 cells/100 mm tissue culture dish and
cultured for 24 h. Cells were transiently transfected
with roGFP2 plasmid DNA at 10 μg/dish for 6 h
using ExGen 500 transfection reagent (Fermentas
International Inc, Burlington, CA). After 6 h, excess
roGFP2 plasmid DNA was removed by changing the
culture media, and cells were incubated for a further
24 h. Cells were re-plated at a density of 2x105
cells/dish in 35 mm glass-bottomed confocal culture
dishes for 24 h to allow cells to adhere. For cell
treatment, 50 μM tBHP or 10 μM BE + 50 μM tBHP
were added with continuous monitoring of 405
nm/488 nm excitation fluorescence changes by
confocal microscopy. roGFP2 plasmid DNA was
obtained as a gift from Professor James Remington
via a Material Transfer Agreement between Western
University and the University of Oregon.

Redox Two-Dimensional SDS-Polyacrylamide
Gel Electrophoresis (R2D SDS-PAGE)
We recently described this procedure (adapted from
Cumming et al (42)) in detail elsewhere (11) so a
condensed version appears here. Cells, were treated,
lysed and centrifuged for 3 min at 500xg. Cell pellets
were washed with PBS, re-centrifuged, resuspended
in ice-cold PBS with 40 mM IACD, centrifuged at
500xg for 3 min and resulting pellets resuspended in
60 µL lysis buffer and frozen in liquid nitrogen. At
the time of analysis, lysates were thawed in a water
bath at room temperature and centrifuged for 10 min
at 14,000xg. The supernatant was transferred to a
fresh tube and assayed for protein content (37).
An equal volume of Laemmli sample buffer,
without reducing agents, was added to solubilized
cytosolic extracts. SDS-PAGE gels (10%
acrylamide, 1.0 mm thickness) were prepared
(11,42), and protein samples (75 or 85 µg) subjected
to electrophoresis in the first dimension for 5 h at
constant current (25 mA) using a Bio-Rad Protean II
apparatus (11). After electrophoresis, the gel lanes
containing the separated proteins were cut and
immersed in Laemmli sample buffer containing 100
mM DTT for 20 min. Following a brief wash with
electrophoresis running buffer, the gel slices were
immersed again in Laemmli sample buffer
containing 100 mM DTT for 10 min. Each gel strip
was then applied horizontally to another gel (10%
acrylamide, 1.5 mm thickness), and electrophoresis
was performed in the second dimension for 14 h at
constant current (10 mA/gel). Gels were fixed in
50% methanol, 5% acetic acid for 20 min, then
silver-stained (11,43).

Analysis of S-Glutathionylated (PSSG) Proteins
by One-Dimensional Non-Reducing SDS-PAGE
plus Western Immunoblot
WT- or ChAT-HEK 293 cells were plated at 8x105
per well in 6-well plates and cultured for 24 h.
Culture media was replaced with PBS before
treatment with TCM constituents at 0-100 μM for 30
min prior to addition of 0-250 µM tBHP for 30 min.
Cytosolic fractions containing 75 μg protein were
obtained (see GSH analysis above) and resolved
using 4-12.5% non-reducing SDS-PAGE gradient
gels. Following electrophoresis, proteins were
transferred to PVDF membranes (PALL Corp., Ann
Arbor, MI), membranes were blocked overnight at
4°C using Tris-saline buffer, pH 7.4 with 5% skim
milk powder. Blots were probed with either antiGSH antibody (1:2,000 dilution) or with anti-ChAT
antibody (14) (1:2,000) and anti-β-actin monoclonal
antibody for 1 h. Following washing (Tris-saline
buffer containing 0.1% Tween 20), membranes were
incubated with horseradish peroxidase-linked anti-

Mass Spectrometry (MS)
Protein spots that exhibited reproducible migration
following R2D SDS-PAGE were excised (Ettan Spot
Picker, General Electric Healthcare, Piscataway,
NJ). In-gel digestion with sequence grade trypsin,
and lyophilization were carried out with a Mass Prep
Automated Digestor (Waters, Milford, MA).
Lyophilized peptide samples were dissolved in 10%
acetonitrile and 0.1% trifluoroacetic acid (5 µl), then
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increased LDH release (38%) (P<0.05). Importantly,
when added for 30 min prior to tBHP treatment, all
TCM preparations tested were chemoprotective,
significantly reducing LDH release from cells
(P<0.05). There were no significant differences
between MIX, MIX-S or Sal for the attenuation of
tBHP-mediated LDH release at the concentrations
tested. Acute treatment of cells with 100 µM Sal
resulted in moderate cytotoxicity (23% LDH release
compared to vehicle-treated control cells, P<0.05)
(data not shown).
Of interest, ChAT-HEK 293 cells treated with
vehicle (0.2% DMSO) released significantly more
LDH than did WT-HEK 293 cells (Fig. 3),
suggesting the bioengineered cells may be under
greater oxidative stress. Importantly, when ChATHEK 293 cells were treated for 30 min with either 5
or 10 µM BE, LDH release was reduced to that from
WT-HEK 293 cells treated with either vehicle or BE.
Treatment of cells with 250 µM tBHP resulted in a
significant increase in LDH from both WT-HEK 293
and ChAT-HEK 293 cells (P<0.05), with the
increase being significantly greater in ChAT-HEK
293 cells than WT cells (23% compared to 11%,
respectively; P<0.05). This suggests enhanced
antioxidant activity in the WT- compared to ChATHEK 293 cells. BE pre-treatment at either 5 µM or
10 µM attenuated tBHP cytotoxicity in both WT- and
ChAT-HEK 293 cells with the effects being similar
at the two concentrations.

mixed at a 1:1 ratio with 5 mg/mL α-cyano-4hydroxycinnamic acid in 6 mM ammonium
phosphate monobasic solution. Sample (0.75 µL)
was spotted on a sample target in duplicate to acquire
matrix-assisted laser desorption/ionization (MALDI)
MS spectra using a BiosystemsR 4700 Proteomics
Discovery System, a matrix-assisted laser
desorption/ionization tandem time-of-flight mass
spectrometer with TOF/TOF optics (MALDI-TOF).
Protein Identification
The MALDI MS spectra were converted into data
with 4000 Series Explorer software (Applied
Biosystems, Foster City, CA), and processed into a
peptide mass fingerprint with Data Explorer software
(Applied Biosystems, Foster City, CA). Protein
identification using peptide mass fingerprints (PMF)
from MALDI MS spectra were obtained using a GPS
engine connected to a Mascot server provided by the
software manufacturer. PMF were compared to
known peptide mass sequences obtained from the
NCBI database. Samples with a PMF with a high
protein score (typically above 90%) were predicted
to identify a particular protein.
Statistics
A one-way analysis of variance (ANOVA) followed
by Bonferroni’s multiple comparison post-hoc test
were used to compare groups. The level of
significance was p < 0.05. When appropriate,
Student’s t-test was used to determine differences
between vehicle control and treatment groups.
Statistics were performed using GraphPad Prism
Version 4.03 (GraphPad Software, Inc).

Intracellular GSH Status and Depletion in WTand ChAT-HEK 293 Cells
GSH is the main non-enzymatic antioxidant defense
within mammalian cells, therefore the concentration
of intracellular GSH was determined in ChAT-HEK
293 cells with or without BE treatment, and with and
without exposure to tBHP (Figure 4). A
concentration-dependent decrease in intracellular
GSH was observed after treatment with 50 or 250
µM t-BHP for 1 h (25% and 50% GSH depletion,
respectively). The GSH content was higher in cells
treated with 50 µM tBHP for 1 h than for 30 min,
showing partial recovery from the oxidative stressor
by 60 min. At a concentration of 10 µM, BE did not
alter cellular GSH content relative to the vehicletreated control cells, nor did it provide protection in
cells that were treated with 50 µM tBHP for 30 min
(36% vs 35% GSH depletion in control vs BE treated
cells).

RESULTS
Protective effects of Sal and TCM Mixtures on
tBHP-mediated Cytotoxicity
In these experiments, we compared the effects of Sal
with those of our defined TCM mixtures on LDH
release from cells as shown in Fig. 2. Treatment of
cells for 30 min with Sal alone at either 10 or 20 μM
did not alter LDH release compared to vehicle
control. Moreover, neither MIX nor MIX-S at 10, 20
or 100 M resulted in LDH release from cells; MIX
contains Sal at a concentration of 25 M. As
expected, the treatment of cells with the oxidative
stressor tBHP (250 µM for 3 h) significantly
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Figure 2: LDH release from WT-HEK 293 cells following pre-treatment with 10, 20 or 100 μM TCM for 30 min, with or
without subsequent exposure to 250 µM tBHP for 3 h. Sal = Schisanhenol; MIX = Equimolar mixture of Sal, Cro, BE, Res;
MIX-S = Equimolar mixture of Cro, BE, Res without Sal. Data are shown from 4 separate experiments and expressed as
mean ± SEM. * denotes P<0.05 compared to DMSO-treated control cells; # denotes P<0.05 compared to 250 μM tBHP.
Statistical significance between the groups was tested using one-way ANOVA followed by Bonferroni’s multiple comparison
test and showed no differences (P>0.05).

Figure 3: Comparison of LDH release from WT-HEK 293 cells to that from ChAT-HEK 293 cells following pre-treatment
with BE for 30 min, with or without subsequent exposure to 250 µM tBHP for 3 h. Data are shown from 4 separate
experiments (mean ± SEM). *P<0.05, WT- compared to ChAT-HEK 293 cells (Student’s t-test).
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(PSSG) in the presence of GSH or to protein-protein
disulfides (PSSP) in its absence (7,35,36). Analysis
of cellular proteins by one-dimensional nonreducing SDS-PAGE coupled with immunochemical
detection using anti-GSH antibodies can be used to
identify PSSG as immunoreactive bands following
electrophoresis of proteins in lysed cells. As shown
in Figure 5, cytosol isolated from WT-HEK 293 cells
treated with either 250 μM or 1 mM tBHP for 30 min
contained many PSSG formed from redox-sensitive
proteins compared to either 0.2% DMSO or BEtreated cells. As verification that PSSG are formed,
these bands were absent in aliquots of these samples
treated with 100 µM DDT which reduces both PSSG
and PSSP. Treatment of cells with 10 μM BE for 30
min did not attenuate PSSG formation initiated by
tBHP, emphasizing that these GSH-containing
disulfides are part of the detoxication process. They
are readily reduced to original PSH and GSH as the
cell returns to its (normal) redox potential (35,36).

On the other hand, BE did provide considerable
protection against the oxidative stress associated
with exposure to 250 µM tBHP for 30 min (25 vs
50% GSH depletion, BE vs control).
Consistent with the greater cytotoxicity of tBHP
in ChAT-HEK 293 cells (Figure 3), pre-treatment of
WT-HEK 293 cells with 10 µM BE for 30 min
effectively prevented subsequent tBHP-mediated
oxidation and also increased intracellular GSH
content (vs controls) more than in the bioengineered
cells. For example, GSH depletion (23%) caused by
50 µM tBHP for 30 or 60 min was completely
prevented by 10 µM BE pre-treatment (P<0.05; data
not shown). However, treatment with BE 10 µM for
24 h was less effective than treatment for 30 min
(30% GSH depletion vs no depletion at 30 min).
These data emphasize the importance of repeated
administration of BE for effective antioxidant
activity due to rapid metabolic conjugation and
elimination from mammalian cells in vitro and in
vivo.

Detection of PSSG, Including ChAT-SSG, and
PSSP Containing ChAT Resulting from
Oxidative Stress in ChAT-HEK 293 Cells

Detection of Protein-GSH Mixed Disulfides
(PSSG) in WT-HEK 293 Cells after Treatment
with tBHP

Treatment of ChAT-HEK 293 cells with 250 µM
tBHP for 30 min also resulted in the formation of
many PSSG, as shown in the non-reduced gel stained
with anti-GSH antibody (Figure 6). Of particular
interest is the strong, single protein band with an

During oxidative stress, proteins with reactive
cysteine thiol residues (PS-) can be reversibly
oxidized to sulfenic acids (PS-OH) which are
converted either to S-glutathionylated proteins

Figure 4: Glutathione content of ChAT-HEK 293 cells treated with 10 µM BE for 30 min, followed by exposure to either 50
or 250 µM tBHP for 1 h. Data shown are from 3-5 individual experiments (mean ± SEM). * P < 0.05, # P < 0.001, vs vehicletreated (control) cells (one-way ANOVA followed by Bonferroni’s Multiple Comparison Test).
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regulated protein, as suspected from the cysteine
array identified earlier in its crystal structure (44,45).
These could be homodimeric or heterodimeric ChAT
disulfides.
The greater intensity of the ChAT disulfide band
in BE and EtGSH treated cells suggests these
chemicals protected against cytotoxicity by
preventing further oxidation of ChAT to tri- and
poly-sulfides and/or attenuated oxidation of ChAT to
its more reactive sulfenic acid derivative (ChAT-SOH).

apparent molecular mass near 62 kDa. This protein
is probably ChAT-SSG because a prominent
immunopositive band of identical molecular mass is
present when the blots were stripped and re-probed
with anti-ChAT antibody. The fact that each of the
bands associated with PSSG virtually disappears
upon reduction of cell lysates with 100 mM DTT
confirms they are disulfides formed from redox
regulated proteins with reactive cysteine thiols. The
disappearance of higher molecular mass ChATpositive bands from the reduced lysates of cells
treated with tBHP demonstrates that ChAT is a redox

Figure 5: tBHP induces the formation of S-glutathionylated proteins (PSSG). Top Large Panel. PSSG were detected by
immunoblotting with anti-GSH antibody following the separation of proteins from cell cytoplasm on one-dimensional nonreducing SDS-PAGE gels; each lane was loaded with 5 μg cytoplasmic protein. Cytoplasm was prepared from WT-HEK 293
cells exposed to either 250 µM or 1 mM tBHP for 30 min, with or without pre-treatment with 10 µM BE for 30 min. Middle
Large Panel. As a control, 100 µM DTT was added to aliquots of cytoplasm, which reduces PSSG and PSSP. Bottom Panels.
Immunoblots were probed with anti-β-actin antibody to determine if protein loading was uniform. The immunoblots shown
are representative of data obtained in three independent experiments. Bottom panels; Lanes: 1, control; 2, 10 µM BE; 3, 250
µM tBHP; 4, 1 mM tBHP; 5, 10 µM BE + 250 µM tBHP; 6, 10 µM BE + 1 mM tBHP.
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Figure 6: tBHP- (250 µM, 30 min) initiated formation of PSSG and PSSP including ChAT-SSG (detected by anti-GSH and
anti-ChAT) as well as homodimeric or heterodimeric disulfides (ChAT-SSP and/or ChAT-SS-ChAT) detected by anti-ChAT
antibody) in cytosol from ChAT-HEK 293 cells. To validate the presence of PSSG and PSSP, an aliquot of each supernatant
was reduced with 100 mM DTT upon which disulfide spots disappeared. β-actin was analyzed as a protein loading control.
The constituents of the various incubation mixtures containing ChAT-HEK 293 cells are shown at the bottom of the figure.
Ethyl glutathione (EtGSH; 2.5 mM) was used to increase the intracellular GSH content in some experiments.

Initially, roGFP2 was primarily in its reduced form
(preponderance of green compared to red
fluorescence at time = 0 min; left panels of Figure 7),
an indication of healthy mammalian cells. The ratio
of fluorescence intensity at excitation wavelengths of
488 nm/405 nm was 7.35 ± 0.54 (mean ± SEM, n =
8) prior to the addition of tBHP to the cells (time = 0
min). roGFP2 expressed in the WT-HEK 293 cells
became oxidized upon the addition of 50 µM tBHP
to the medium, and cells showed membrane blebbing
as they underwent oxidative stress (discussed
below). Thirty min following the addition of tBHP,
the 488/405 nm excitation ratio roGFP2 was
decreased by about 55%. As a sign that the cells were
recovering, oxidative stress-mediated blebbing was
markedly less by 40 min and disappeared by 60 min
(right panels of Figure 7). However, the cells did not
return to their initial redox status at 60 min of
treatment with tBHP.

Imaging Dynamic Redox Changes in WT-HEK
293 Cells with Transfected roGFP2
Dynamic changes in the intracellular redox status of
WT-HEK 293 cells transiently transfected to express
roGFP2, a novel fluorescent reagent that tracks redox
changes in the cytoplasm of living cells (40,41), were
monitored in real time by confocal laser microscopy
following tBHP treatment. Results are presented as
images of cells obtained at an emission wavelength
of 530 nm with excitation at both 488 nm (reduced
roPFG2) and 405 nm (oxidized roGFP2). Changes
were quantified by measuring the ratios of
fluorescence from excitation at 488 nm to 405 nm
using pixel counting software (ImageJ software,
NIH). Changes in the intracellular oxidation state
were determined by analyzing roGFP2-expressing
WT-HEK 293 cells for 1 h after addition of 50 µM
tBHP to medium containing these cells (Figure 7).
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Figure 7: Dynamic intracellular oxidation of WT-HEK 293 cells transiently transfected with roGFP2 following treatment
with tBHP (50µM for 1 h). Cells were visualized with a Zeiss LSM-510 META laser scanning microscope using dual
excitation (405 and 488 nm), emission of 505 nm. Changes of fluorescence were quantified using pixel counting software.
Red was selected as the colour for oxidized roGFP2 and green for the reduced form of this protein.

in reduced/oxidized roGFP2 fluorescence ratio was
16% at 30 min (P< 0.05 compared to tBHP treatment
only). Confocal microscopy also showed that BE
effectively attenuated the cell membrane blebbing
induced by tBHP exposure, consistent with its
chemoprotectant properties (data not shown)..

Attenuation of tBHP-mediated Oxidation by BE
in ChAT-HEK 293 Cells Transfected with
roGFP2 and Imaged by Confocal Microscopy
The treatment of roGFP2-expressing ChAT-HEK
293 cells with 10 µM BE for 30 min prior to their
exposure to 50 µM tBHP significantly attenuates
intracellular oxidation of roGFP2 (Figure 8).
Changes in cellular roGFP2 fluorescence (488/405
nm excitation ratio, emission at 505 nm) demonstrate
divergence from BE-treated cells as early as 6 min
after exposure to the oxidative stressor, although the
differences did not become significant until 15 min
after tBHP addition. Relatively little oxidation of
roGFP2 is associated with tBHP exposure in the BEtreated cells over the 30 min course of dynamic
monitoring. This was not the case with the tBHPtreated cells. There was no indication of roGFP2
reduction in the cells treated only with tBHP over 30
min. More specifically, treatment with 50 µM tBHP
caused a 44% decrease of reduced/oxidized roGFP2
fluorescence ratio by 14 min which increased to 55%
by 30 min. In cells pre-treated with BE, the decrease

Identification of Important Redox-Regulated
Proteins in WT-HEK 293 Cells by Mass
Spectrometry and Peptide Mass Fingerprinting
(MS-PMF) Following Separation by R2D SDSPAGE
We chose to use post-translational modifications of
reactive cysteine thiol residues of redox-regulated
proteins in WT-HEK 293 cells as an endpoint to
compare the ability of TCM constituents and defined
mixtures to attenuate oxidation of the disulfide
proteome by cell permeant tBHP. Initially, we
selected 9 protein spots from the redox 2D protein
profile of WT-HEK 293 cells for potential
identification and “biomarker” use.
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Figure 8: Protective effects of 10 µM BE pre-treatment for 30 min on the intracellular oxidation of roGFP2 in transfected
ChAT-HEK 293 cells initiated by 50µM tBHP. Cells were imaged with a Zeiss LSM-510 META laser scanning confocal
microscope using dual excitation at 405/488 nm with emission at 505 nm. Changes in the ratio of roGFP2 fluorescence
measured at 488/405 nm were quantified by using ImageJ pixel counting software. Data are expressed as the percentage of
fluorescence ratio measured in control cells at time = 0 min. The data shown are from 5 - 8 individual experiments (mean ±
SEM); * P < 0.05 vs 50 µM tBHP treated cells (Student’s t-test).

certainty for which the PMF identifies a specific
protein. MS-PMF analysis of spots 2 (human prx 2)
and 3 (human prx 3) in WT-HEK 293 cells yielded
PSC percentages >90%, whereas that of spot 1
(human prx 1) was only 77%. Six other protein spots
that we analyzed did not yield acceptable PSC data
demonstrating that in our hands protein identification
by R2D-SDS-PAGE-MS is limited to proteins that
are expressed in relatively large amounts.

However, we subsequently focused on 2 prominent
spots (labelled 2 and 3 in Figure 9A) and a minor spot
(labelled 1) that were present in all samples from
control cells (Fig. 9A). These 3 spots showed
dramatic changes upon tBHP treatment, suggesting
their importance during oxidative/nitrosative stress.
We positively identified two of these proteins
[spots # 2 and 3] by MS-PMF (Table 1 for spot # 2)
following spot picking and in-gel digestion with
sequence grade trypsin, and have tentatively
identified the third protein [spot # 1] (Table 2). The
PMF generated for each trypsin-digested protein spot
was compared to known peptide mass sequences
available on the NCBI database using a search
engine (MASCOT, Matrix Science, Boston, MA),
and the protein score confidence (PSC) indicated as
a percentage for each protein PMF was reported. The
PSC is a statistical calculation that compares how
closely the acquired PMF compares to known
protein peptide sequences and is a measure of the

Attenuation of Oxidation of Prx 2 and Prx 3
Thiols by BE Pre-treatment of WT-HEK 293
Cells Exposed to tBHP
Cytosolic prx 2 and prx 3, and to a lesser extent
mitochondrial prx 1, are clearly visible upon R2D
SDS-PAGE analysis of cytosol from vehicle-treated
WT-HEK 293 control cells (Figure 9A). This is the
case for both lysate and cytosol from all untreated or
solvent treated WT-HEK 293 cell preparations we
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analyzed by R2D SDS-PAGE. Treatment of these
cells with 10 µM BE for 30 min (Figure 9B)
increases the size of the spot for each of these
proteins slightly, indicative of more prx disulfide (vs
solvent controls). The disulfide-linked dimeric
intermediary prx (prx-SS-prx) is present in each case
because these disulfides are part of the 2-cysteine prx
catalytic recycling mechanism that occurs with prx
1- prx 4 (46-49). The presence of prx 1, prx 2 and prx
3 in their disulfide-linked dimeric form in untreated
WT-HEK 293 cells is related to their physiological
role, the reduction of µM concentrations of
intracellular H2O2 (49). Prx protein sulfinic acids are

not reduced by DTT so they are not visible as
individual spots following R2D SDS-PAGE, but
instead run on the prominent diagonal line in the gels
that contains all proteins that are not in a disulfide
form. Prx 1, 2 and 3 occur as homodimeric disulfides
(45-48) that are reduced by DTT in the second
dimension of R2D SDS-PAGE. As their molecular
weight is halved (protein disulfide to 2 molecules
protein thiol), these prxs are visible as single spots
below and to the right of the prominent diagonal line
that is formed by the mass of cellular non-disulfide,
non-redox regulated proteins.

Figure 9: The protective effects of BE on tBHP-mediated intracellular oxidation of cytosol from WT-HEK cells was
evaluated by R2D SDS-PAGE coupled with silver staining of gels. A = vehicle (0.2% DMSO)-treated control cells; B = cells
treated with 10 µM BE for 30 min; C = cells treated with 50 µM tBHP for 30 min; and D = cells treated with 10 µM BE for
30 min prior to a 30 min treatment with 50 µM tBHP. Cytosol was isolated from cells and 75 µg protein analyzed for each
treatment group. All gels were run in triplicate and sets of gels were silver stained simultaneously, with the experiment
repeated three separate times with different cell cultures (i.e. a total of 9 gels were analyzed for each treatment group). All
spots marked were present on each gel in the respective treatment groups.
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Table 1: Mass spectrometric peptide mass fingerprinting (MS PMF) sequence data for protein spot 2 from WT-HEK
293 cells. Data from MASCOT ®, a search engine which compared the PMF of tryptic digests of protein spot 2 against
an NCBI database of known protein peptide masses used to determine the identity of the disulfide bonded protein
separated by redox 2D-gels. Protein identified was peroxiredoxin 2 isoform a (Homo sapiens), a major redox-regulated
protein in lymphocytes.
Peptide Information
Calc.
Observ
± da
± ppm
Start
End
Sequence
Mass
Mass
Seq.
Seq.
765.39
789.41
862.50
924.44
972.55
1023.54
1179.64
1211.67
1734.97
1863.07

765.39
789.41
862.49
924.44
972.55
1023.54
1179.63
1211.67
1734.95
1863.02

-0.0024
-0.0012
-0.0108
-0.0003
-0.0049
0.00
-0.0085
-0.0039
-0.0268
-0.0523

-3
-2
-13
0
-5
1
-7
-3
-15
-28

62
151
128
120
8
111
110
140
93
92

67
157
135
127
16
119
119
150
109
109

AEDFRK
SVDEALR
GFIIDGK
TDEGIAYR
IGKPAPDFK
LSEDYGVLK
RLSEDYGVLK
QITVNDLPVGR
EGGLGPLNIPLLADVTR
KEGGLGPLNIPLLADVTR

Table 2: Proteins that form intermolecular disulfide bonds during tBHP-induced oxidative stress in WT-HEK 293 cells
separated by R2D SDS-PAGE and identified by MS-PMF.
Protein
Protein Name
Accession No.
Protein
Protein
Protein
Spot
Score %
MW
PI
2
Peroxiredoxin 2 isoform a
gi|55959887
90.18
19134.7
6.41
[Homo sapiens]
3
Peroxiredoxin 3, isoform CRA_c
gi|32189392
100
22049.3
5.66
[Homo sapiens]
1
Peroxiredoxin 1
gi|119569783
76.99
11157.8
6.06
[Homo sapiens]

shown in Figure 10. The solvent controls for two
different sets of experiments (Figures 9A and 10A)
are very similar; prx 2 (most prominent spot), prx 3
and prx 1 (least prominent spot) are clearly visible in
each case. Pre-treatment with Sal and MIX showed
an apparent dose response in that spots formed by the
reduction of the dimeric disulfide forms of prx 2 and
prx 3 are present in slightly higher concentrations
(larger spots) in cells treated with 100 vs 20 µM Sal
(Figures 10C vs 10B); and with 100 vs 20 µM MIX
(Figures 10E vs 10D). In addition, the prx 2 spot
appears slightly larger in 20 µM MIX-S vs 20 µM
MIX treated cells (Figures 10F vs 10D) but is not as
intense. Thus, not even a slight difference can be
inferred between these two treatment regimens. In
common, each of the TCM treatments evaluated
reduces the cytosolic compartment of HEK 293 cells,
an observation previously made with BE, Cro, Res
and Sal and these two TCM mixtures in Jurkat E6.1
cells (11).

Treatment of cells with 50 µM tBHP for 30 min
(Figure 9C) resulted in the disappearance of prx 1
and prx 3 and a marked diminution of prx 2. This is
due to the increased formation of prx sulfinic acids
at the expense of prx disulfide-linked dimers (48), a
reaction termed hyperoxidation. Pretreatment of the
cells with 10 µM BE for 30 min before tBHP
exposure partially attenuated the effects of this
oxidative stressor. Thus, the prx 2 spot is more
intense than in cells treated with tBHP alone, and prx
3 becomes visible in BE-pretreated cells treated with
tBPH but not in cells treated with tBPH alone.
Effect of Treatment of WT-HEK 293 Cells with
Schisanhenol (Sal) or Two Defined Equimolar
TCM Mixtures on the Disulfide Proteome, With
or Without Subsequent Exposure to tBHP
The effects of pre-treatment of WT-HEK 293 cells
with Sal (20 and 100 µM), MIX 1 (20 and 100 µM)
or MIX-S (20 µM) on the disulfide proteome are
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D

E

Figure 10. Effects of antioxidant pre-treatments on the disulfide proteome of WT-HEK 293 cells analyzed by redox 2D
PAGE. Cells were treated with 0.2% DMSO (solvent control) or the various TCM treatments for 30 min. Cytosolic proteins
(75 µg) were loaded onto each gel. A. DMSO control, B. SAL 20 μM, C. SAL 100 μM, D. MIX 20 μM, E. MIX 100 μM, F.
MIX-S 20 μM. All gels were run in triplicate from three different cell cultures. Proteins spots marked 1, 2 and 3 were present
on each run and were identified by mass spectrometry to be peroxiredoxins (prx) 1, 2 and 3, respectively (Table 2).

In cells treated with TCM regimen first and then
with tBHP, minor chemoprotection was observed
with some (Figures 11C-11F) but not all of the
treatments (Figure 11B). The prx 2 spot is somewhat
more intense in cells treated with 100 µM (Figure
11C) compared to 20 µM Sal (Figure 11B) and 100
µM (Figure 11E) compared to 20 µM MIX (Figure
11D). Of significance to our interest in defined TCM
mixtures as chemoprotectants, the prx 2 spot is more
intense with 20 µM MIX (Figure 11D) and 20 µM

As opposed to the R2D SDS-PAGE gels that
were prepared for the analysis of cytosol from WTHEK 293 cells treated only with TCM constituents
that contained prominent spots for prx 2 and prx 3
(Figure 10B-10F), gels from WT-HEK 293 cells
treated in the same experiments with 50 µM tBHP
contained a much less intense spot for prx 2 and no
spots for prx 3 or prx 1 (Figure 11A), equivalent to
data with a different cell culture shown in Figure 9C.
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formation (blebbing). We observed this phenomenon
by confocal microscopy in WT- HEK 293 cells
(Figure 7) that had been treated with tBHP. Bleb
formation is due to the oxidative modification of free
thiol groups in cytoskeletal proteins (54), including
actin which contains a reactive cysteine thiol moiety
(Cys374), forms a S-glutathionylated derivative and
is redox-regulated (55,56). Of importance, tBHPmediated blebbing was prevented in WT- HEK 293
cells (Figure 7) by pre-treatment with 10 µM BE, an
excellent example of chemoprotection.
LDH is a cytosolic enzyme whose release into
the cell medium (in vitro) or blood (in vivo) is a
sensitive assay for cytotoxicity. Loss of cellular LDH
due to impaired cell membrane integrity is an early
indicator for cell death by both apoptosis and
necrosis. Of the TCM antioxidants evaluated here
(Figures 2 and 3), only treatment with 100 µM Sal
for 30 min caused significant cytotoxicity to WTHEK 293 cells (23% LDH release). Treatment of
cells with 10 or 20 µM Sal did not cause cytotoxicity
(Figure 2).
All TCM treatments attenuated
cytotoxicity due to exposure to 250 µM tBHP but
there were no significant differences between Sal and
the two mixtures, MIX (equimolar Sal, Cro, BE, Res)
and MIX-S (equimolar Cro, BE, Res) in this regard.
ChAT is a critical enzyme that catalyzes the
synthesis of the neurotransmitter acetylcholine. It
has an unusually high number of cysteine amino acid
residues (3.2% of total) and is a probable site for
oxidative
stress-mediated
neurotoxicity
(14,15,44,45). The availability of stably-transfected
ChAT-expressing HEK 293 cells (14) allowed us to
compare tBHP toxicity in ChAT-HEK 293 to WTHEK 293 cells (Figure 3). Vehicle-treated ChATexpressing cells released more LDH into the medium
than did WT-HEK 293 cells, but this cytotoxicity
was decreased to control values by treatment of
ChAT-HEK 293 cells with either 5 or 10 µM BE.
Upon exposure to 250 µM tBHP for 3 h, the ChATHEK 293 cells released twice as much LDH into the
medium as did the WT-HEK 293 cells. Attenuation
of tBHP-mediated cytotoxicity by pre-treatment of
the cells with 10 µM BE was significantly less
effective in ChAT-expressing than it was in WTHEK 293 cells (Figure 3).
The tripeptide, GSH (γ-Glu-Cys-Gly) is present
at high concentrations (0.5-10 mM) in mammalian
cells. It represents approximately 95% of total nonprotein sulfhydryls and is the major modulator of
cellular redox equilibrium (57).

MIX-S (Figure 11F) than with 20 µM Sal (Figure
11B). Although these changes are not dramatic, they
were observed in each of the separate experiments
(n=9 gels for each treatment we conducted.
DISCUSSION
Experiments described in this paper were designed
to evaluate the ability of single TCM constituents
(Sal, BE, Cro or Res, with emphasis on understudied
Sal and well-studied BE (24)) with known
chemoprotectant
properties
at
nontoxic
concentrations (16-18,20,24,25,28), and of two
novel defined mixtures with lower cytotoxicity than
individual constituents in experiments performed in
our laboratory with Jurkat E6.1 cells (11), to
attenuate tBHP-mediated oxidative stress in WTHEK 293 cells and ChAT-HEK 293 cells.
The individual chemicals were chosen because
their structures and chemical classes are divergent
(Figure 1A – 1D) as are some of their mechanisms of
chemoprotection against oxidative and nitrosative
stress (20,21,24-28). These experiments have
limitations because chemoprotection in vitro can
vary markedly from that in vivo because of
differences in absorption, distribution, metabolism
and elimination (i.e. pharmacokinetics). This is also
an area where carefully chosen TCM mixtures can
provide superior chemoprotection compared to
single TCM constituents while minimizing the
adverse effects often associated with administration
of complex TCM prescriptions (50).
tBHP is a membrane penetrable alkyl
hydroperoxide reagent widely used to induce
oxidative stress in cells (51-54). The toxicity of tBHP
is attributed to the generation of butoxyl radicals due
to the Fenton reaction which can subsequently
initiate lipid peroxidation, modify cellular lipids and
proteins
(Figures 9-11), affect cell integrity and
signalling, and form covalent bonds with cellular
molecules resulting in cell injury. Alternatively, the
free radicals produced from tBHP (butoxyl and other
ROS, including H2O2 and NO, an RNS) can directly
deplete intracellular thiols and GSH (Figure 4),
thereby decreasing the capacity of nonenzymatic
antioxidant systems and enzymatic radical
detoxication (for example by GSH transferases and
GSH peroxidases), eventually leading to cell death.
An interesting phenomenon of tBHP toxicity in
hepatocytes and other cells is plasma membrane bleb

676

J Pharm Pharm Sci (www.cspsCanada.org) 18(4) 661 - 682, 2015

Figure 11. Effects of 50 μM tBHP treatment with or without TCM pre-treatment on the disulfide proteome of WT-HEK
293 cells analyzed by redox 2D SDS PAGE. Cells were pre-treated with each of the antioxidants for 30 min followed by
tBHP for 30 min. Cytosolic proteins (75 μg) were loaded onto each gel. A. tBHP 50 μM, B. SAL 20 μM + tBHP 50 μM, C.
SAL 100 μM + tBHP 50 μM, D. MIX 20 μM + tBHP 50 μM, E. MIX 100 μM + tBHP 50 μM, and F. MIX-S 20 μM +
tBHP 50 μM. All gels were run in triplicate with cells from three individual cell cultures. Protein spot 2, designated by
arrows in B through F was identified as peroxiredoxin 2 (Tables 1 and 2).

concentration-dependent depletion of GSH was
noted in ChAT-HEK 293 cells (20% at 50 µM, 50%
at 250 µM tBHP for 60 min; Figure 4). A significant
difference between the HEK cell types studied is that
10 µM BE was very effective at attenuating GSH
depletion in WT cells but not in ChAT-HEK 293
cells, which appear to be under more oxidative stress
(Figure 4). Of importance, treatment with BE (10
µM) for 24 h was less effective than 30 min treatment
in preventing GSH depletion in WT cells. This
emphasizes the importance of pharmacokinetics in

The cytoplasmic ratio of reduced to oxidized
glutathione (GSH/GSSG) in healthy cells
approaches 100/1, and steady state is maintained by
NADPH-dependent GSH reductase (57). Under
conditions of moderate oxidative stress, a limited
amount of GSH is converted to GSSG which alters
the GSH/GSSH ratio as well as cellular redox status.
In this study, we observed rapid, concentrationdependent GSH depletion after exposure of WTHEK 293 cells to increasing concentrations (10 to
250 µM) of tBHP (data not shown). A similar
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higher molecular wt bands than 62 kDa that stained
with anti-ChAT upon reduction with DTT. Whether
these are monomeric (ChAT-SS-ChAT) or dimeric
ChAT disulfides (ChAT-SS-P) is unknown.
Real-time visualization of intracellular redox
status of tBHP treated WT-HEK 293 cells (Figure 7)
and ChAT-HEK 293 cells (Figure 8) via confocal
microscopy was made possible by monitoring
oxidation-reduction of the disulfide-dependent
reporter protein, roGFP2 (40,41). This novel
technology allowed us to monitor oxidation of the
cell cytosol and blebbing concomitantly. The fact
that blebbing disappeared before the cells returned to
their initial redox equilibrium indicates there is a
threshold for oxidative stress-induced blebbing in
HEK 293 cells transiently transfected with roGFP2.
Of importance, BE (10 µM) is able to prevent tBHP(50 µM) mediated oxidation of cytosolic roGFP2 in
HEK 293 cells over the 30 min these effects were
monitored (Figure 8). Part of this BE effect may
result from its ability to decrease intracellular H2O2
concentrations (20).
Because PSSG and PSSP were formed in
abundance during tBHP treatment of WT- (Figure 5)
and ChAT-HEK 293 cells (Figure 6) we required a
more sensitive technique for the analysis of PSSP,
i.e., the disulfide proteome (7,35,36,42). We utilized
reduced two-dimensional SDS-PAGE (R2D SDSPAGE) for this purpose (Figure 9). This technique is
also called non-reducing/reducing “diagonal” PAGE
and is an established method to resolve cytoplasmic
proteins that undergo disulfide bond formation
following oxidative stress (42). After staining the
gel, proteins that do not contain any disulfide bond
form a prominent diagonal line; proteins that are
covalently linked by an intermolecular disulfide
bond are found below the diagonal line (right side)
and proteins that form intramolecular disulfide bonds
are found slightly above the diagonal line (left side)
formed by unmodified proteins. We noted more than
25 homodimeric or heterodimeric protein disulfides
formed in WT-HEK 293 cells exposed to tBHP
throughout the course of our study. Important for our
purposes, tBHP always resulted in the disappearance
or decreased size of two prominent cytosolic
proteins, prx 2 and prx 3 upon R2D SDS-PAGE
analysis. We identified these proteins using MALDIMS FSM (Table 1). The prxs exist, in part, as
homodimeric protein disulfides, the reason they are
resolved upon R2D SDS-PAGE. We selected prx 2
and prx 3 as our primary biomarkers for monitoring
change in the disulfide proteome because they: i) are

selection of TCM agents and mixtures for in vivo
(including human) studies. As mentioned above, BE
is rapidly eliminated due to conjugation and active
transport into urine. Thus, repeated administration is
required for rapidly eliminated chemicals such as BE
to be effective chemoprotectants in vivo although
preparation of more-slowly metabolized derivatives,
such as methoxyl ethers increases the half-life of
polyphenols (58).
Proteins with ionized cysteine thiol residues at
physiological pH (approximately 400 such proteins
currently known) are more readily oxidized to their
PS-OH derivatives than unionized protein thiols
under conditions of mild and moderate oxidative or
nitrosative stress (8,29,30). Post-translational
modification at reactive cysteine thiols forms
products that are biologically reducible (PSSG,
PSSG-NO; PSSP; P’SSP). However, further
oxidation leads to products that cannot be readily
reduced enzymatically, including protein sulfinic
acids (PSO2H), protein sulfonic acids (PSO3H) and
polymeric protein disulfides ((PSSPSSP’SSPS’’)x).
Formation of these latter products frequently occurs
concomitantly with severe cytotoxicity and cell
death. Post-translational reactions at ionized cysteine
thiol are the basis for selective redox regulation of
many proteins including the prxs (7,47,48). We
monitored
S-glutathionylation
of
proteins
subsequent to treatment with tBHP in both WT(Figure 5) and ChAT-HEK 293 cells (Figure 6) by
non-reductive SDS-PAGE with detection of PSSG
by a monoclonal antibody to GSH. In short, many Sglutathionylated proteins were formed during
exposure to tBHP, verified by reduction of aliquots
of cell lysates or cytosol with 100 mM DTT upon
which anti-GSH staining was obliterated (Figure 6).
A more sophisticated approach was possible
with tBHP-oxidized ChAT-HEK 293 cells (Figure 6)
because of the availability of anti-ChAT antibody
(15). Rylett and her colleagues postulated that ChAT
is a redox-regulated protein from their resolved
crystal structure of human ChAT (44,45). Analysis
of the protein crystals identified a cysteine tetrad at
the active site of the enzyme. As ionized cysteine
thiol is a common component of the active site of
enzymes, they predicted that ChAT is redoxregulated (45). The experiments reported here
confirm this fact. Under conditions of oxidative
stress (Figure 6) ChAT is converted to both ChATSS-G, a prominent band at 62 kDa which stained
both with anti-GSH and anti-ChAT antibodies, and
protein disulfides, demonstrated by disappearance of
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for diseases caused or promoted by ROS/RNS. In
this regard, such mixtures might best serve as
complementary or adjunct therapy.
There are two potential advantages of welldefined TCM mixtures over single TCM constituents
in therapy. First, potent compounds that exert their
chemoprotective properties via different molecular
mechanisms are likely to be more active in
combination that alone. Second, compounds with
different pharmacokinetic properties might be
combined to increase half-life and prolong desired
pharmacodynamic effect(s). Sal is an example of a
TCM constituent with prolonged half-life, and
prolonged biological activity. Sal contains 6
phenolic hydroxyl groups, which are responsible for
antioxidant activity. However, 5 of these phenols are
masked as methyl ethers in Sal (Figure 1A, 57,58).
These 5 methoxyl groups result in more efficient
absorption due to increased lipophilicity of Sal (vs
polyphenols with six free phenols), as shown by its
short half-life (approximately 1 h) in plasma (30).
To be efficiently eliminated, the methoxyl groups of
Sal must be O-demethylated by cytochrome P450dependent oxidation, a slower Phase 1 reaction
which also unmasks antioxidant phenolic groups.
Once formed, phenols are rapidly conjugated by
Phase 2 enzymes and the sulfate or glucuronide
conjugates rapidly eliminated by active transporters
in the liver (bile) and kidney (urine),
We believe compounds similar to Sal can serve
as important components of defined TCM mixtures
used for chemoprotection in vivo due to their
prolonged antioxidant activity and delayed
metabolic clearance. Another approach to achieve
the same pharmacokinetic and pharmacodynamic
goals is by synthesis of lipophilic derivatives of
antioxidant phenolic hydroxyls in TCM ingredients.
Thus, five novel alkyl ether (ethyl, butyl, pentyl,
hexyl and octyl) derivatives of Res were recently
prepared which increased bioavailability compared
to Res. Significantly, these derivatives retained the
pharmacodynamic (melanogenesis inhibition) effect
of Res evaluated (60) so that a mixture of Res and
Alkyl-O-Res could be formulated to have both
immediate and more prolonged biological activity
based on rate of metabolic elimination and
unmasking of antioxidant phenolic groups over time.
In this respect, the metabolism of the ethyl ether
would be more rapid than with any of the other alkyl
ethers, with O-deoctylation being the slowest P450catalyzed reaction in this series.

prominent protein spots present in every R2D SDSPAGE analysis of WT-HEK 293 cell lysate we have
ever run; ii) show dramatic changes (i.e. disappear)
as a result of oxidative stress-mediated
hyperoxidation; iii) are well characterized and
known to be localized in the cytosol of cells (46,48);
and iv) we confirmed their identity by MS-FSM
analysis of WT-HEK 293 cells.
Based on changes in the size or intensity of
silver-stained spots for prx 2 and prx 3 (and to a more
limited extent, prx 1) in the R2D SDS-PAGE
analysis of the 50 µM-tBHP oxidized disulfide
proteome of WT-HEK-293 cells, we conclude that at
equimolar concentrations, MIX-S (equimolar BE,
Cro, Res) and MIX (equimolar Sal, BE, Cro, Res) are
as protective or even slightly more cytoprotective
than the single TCM constituents, Sal (Figure 11) or
BE (Figure 9). Of significance, each TCM treatment
evaluated did provide chemoprotection from
oxidation of the disulfide proteome which is often a
critical early step in cytotoxicity (e.g. cell blebbing)
(54-56).
We are especially interested in the
chemoprotection potential of Sal, a poorly studied
dibenzocyclooctene lignin isolated from Schisandra
rubriflora and characterized in the Chen laboratory
(57,58). Here, we directly evaluated several
properties of pure (>99%) Sal in HEK 293 cells in
culture. In this regard, Sal was cytotoxic at 100 µM
(caused release of approximately 20% intracellular
LDH) but not at 10 or 20 µM (Figure 2). It
significantly attenuated the cytotoxicity of 250 µM
tBHP at 10, 20 or 100 µM showing optimal
protection at 20 µM (Figure 3). Sal (20 µM)
attenuated tBHP-mediated oxidation of the disulfide
proteome but not dramatically. We also evaluated the
effectiveness of Sal as part of an equimolar mixture
(Sal, BE, Cro, Res) compared to an equimolar
mixture containing only BE, Cro and Res in this
study. These two mixtures were almost equivalent in
their ability to attenuate the cytotoxicity, lipid
peroxidation,
protein
carbonylation,
and
hyperoxidation of prx 2 initiated by 400 µM SMXNHOH in Jurkat E6.1 cells (11).
In a previous investigation (11), we showed that
MIX and MIX-S are slightly more effective in
attenuating hyperoxidation of intracellular prx 2 in
Jurkat E6.1 cells exposed to SMX-NHOH than are
equal concentrations of Sal, BE, Cro or Res.
In concert the results from these two studies
suggest that defined mixtures of well characterized
TCM constituents might serve as chemoprotectants
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